Please login to the form below

Lidoderm

This page shows the latest Lidoderm news and features for those working in and with pharma, biotech and healthcare.

Endo also has an existing pain patch in the form of Lidoderm, which contains the active ingredient lidocaine.

Endo agrees $1.6bn deal to buy Paladin Labs

generic competition to Endo's Lidoderm (lidocaine) patch for post-shingles pain - and earnings per share (EPS) of $1.34, up from $1.28 a year earlier. ... Looking at the performance of Lidoderm, which fell 37 per cent, De Silva said that "prescription
Watson settles Lidoderm patent dispute with Endo

Watson settles Lidoderm patent dispute with Endo. Watson can now bring its generic version of the post-shingles pain patch to US market two years early. ... Once another generic product is launched following the 2015 patent expiry, however, Watson will
Global survey shows neuropathic pain under-diagnosed and under-served

Lidoderm is licensed to Endo for sale in the US and Versatis is licensed to Gruenenthal for the UK. ... For Endo in the US, Lidoderm racked up sales of USD 419 million in FY05.

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Pharma deals during August 2013

The deal provides some protection for Endo's top-selling Lidoderm which accounted for 31 per cent of 2012 sales ($947.7m).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Add my company

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

What is blockchain and why should i care - Richard Springham: Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone: Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?: What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...